Makio Shozu
Overview
Explore the profile of Makio Shozu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
206
Citations
1525
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nishikimi K, Tate S, Matsuoka A, Otsuka S, Shozu M, Koga K
J Gynecol Oncol
. 2025 Feb;
PMID: 40017162
Objective: Diaphragmatic resection is frequently required to achieve optimal cytoreduction with no residual disease in patients with advanced ovarian cancer. Pleural effusion and pneumothorax are known short-term postoperative complications of...
2.
Habu Y, Usui H, Hanawa S, Otsuka S, Okuya R, Katayama E, et al.
J Obstet Gynaecol Res
. 2025 Feb;
51(2):e16254.
PMID: 39988469
Aim: Sentinel lymph node (SLN) mapping using indocyanine green (ICG) is an alternative for reducing comprehensive lymph node dissection and its associated morbidity. This trial aimed to assess the efficacy...
3.
Matsuoka A, Mitsuhashi A, Usui H, Otsuka S, Nishikimi K, Tate S, et al.
J Obstet Gynaecol Res
. 2025 Feb;
51(2):e16238.
PMID: 39965797
Introduction: Postoperative spindle cell nodules are benign and reactive lesions that occur at the previous surgical site. It often develops like a sarcoma and is resected via highly invasive procedures....
4.
Shioya M, Takahashi K, Nakano S, Kobayashi T, Koga K, Shozu M
Am J Reprod Immunol
. 2024 Dec;
92(6):e70024.
PMID: 39665768
Introduction: Anticentromere autoantibodies are associated with refractory IVF/ET failure, but causality is unclear. Experimental models are needed. Methods: Immature oocytes collected from 23-day-old mice were matured in vitro for 18 ...
5.
Kaneko M, Ishikawa H, Kaneko T, Sato A, Shozu M, Koga K
J Obstet Gynaecol Res
. 2024 Nov;
51(1):e16171.
PMID: 39605170
Patients with obstructed hemivagina and ipsilateral renal anomaly (OHVIRA) syndrome sometimes present with distinct symptoms related to coexisting urogenital abnormalities. We present a case of refractory abscess formation in a...
6.
Piao H, Ishikawa H, Kobayashi T, Kitajo K, Yamaguchi A, Koga K, et al.
Pediatr Neonatol
. 2024 Aug;
PMID: 39181832
Background: Hypoxic-ischemic (HI) insult in infants induces brain injury and results in motor coordination impairments associated with cerebral palsy; however, preventive measures for HI brain injury in preterm infants remain...
7.
Suzuki Y, Usui H, Katayama E, Sato A, Nakamura N, Nakada E, et al.
Genes Chromosomes Cancer
. 2024 May;
63(2):e23220.
PMID: 38780072
Accurate diagnosis of partial hydatidiform moles (PHMs) is crucial for improving outcomes of gestational trophoblastic neoplasia. The use of short tandem repeat (STR) polymorphism analysis to distinguish between PHM and...
8.
Teramoto S, Ueno T, Aono F, Okubo T, Segawa T, Osada H, et al.
Reprod Biomed Online
. 2024 Apr;
49(1):103864.
PMID: 38688121
Research Question: How, and to what extent, do anticentromere antibodies (ACA) reduce live birth outcomes after ICSI? Study Design: Retrospective cohort study of infertile women aged 30-43 years who underwent...
9.
Fujita M, Nagashima K, Shimazu M, Suzuki M, Tauchi I, Sakuma M, et al.
Int J Cancer
. 2024 Apr;
155(5):905-915.
PMID: 38648390
Japan is lagging in cervical cancer prevention. The effectiveness of a self-sampling human papillomavirus (HPV) test, a possible measure to overcome this situation, has not yet been evaluated. A randomized...
10.
Matsuoka A, Tate S, Nishikimi K, Otsuka S, Usui H, Tajima S, et al.
J Obstet Gynaecol Res
. 2024 Apr;
50(7):1148-1154.
PMID: 38634254
Objective: Therapy-related myeloid neoplasms (t-MNs) are often fatal and arise as late complications of previous anticancer drug treatment. No single-center case series has examined t-MNs in epithelial ovarian cancer (EOC)....